MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$39,361K
Free Cash flow
-$77,201K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Other income
Non-cash interest expense
Net proceeds from sale of equity
Others
Negative Cash Flow Breakdown
Non-cash royalty revenue
Gain from deconsolidation of min...
External expenses
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
Revenues
114,196
External expenses
70,213
Payroll related expenses
39,664
Other operating expenses
24,488
Operating loss
-20,169
Interest expense
55,618
Interest income
345
Other income
72,359
Net loss
-3,083
Depreciation and amortization
9,999
Share-based compensation
13,770
Non-cash royalty revenue
108,588
Non-cash interest expense
54,440
Loss (gain) on sale or disposal of assets, net
-937
Gain from deconsolidation of mink therapeutics, inc
100,924
Loss on impairment of assets
234
Gain on forgiveness of liability
0
Gain on lease terminations
0
Unrealized loss on long-term investments
-26,119
Fair value adjustments
387
Other, net
-2,954
Accounts receivable
1,728
Prepaid expenses
-1,260
Accounts payable
23,500
Deferred revenue
1
Accrued liabilities and other current liabilities
4,499
Other operating assets and liabilities
198
Net cash used in operating activities
-77,195
Proceeds from sale of property, plant and equipment
359
Purchases of property, plant and equipment
6
Purchases of available-for-sale securities
0
Proceeds from sale of available-for-sale securities
0
Purchase of long-term investment
0
Proceeds from sale of long-term investment
841
Net cash provided by investing activities
1,194
Net proceeds from sale of equity
36,136
Net proceeds from sale of subsidiary shares in private placement
0
Proceeds from employee stock purchases and option exercises
169
Purchase of treasury shares to satisfy tax withholdings
87
Purchase of subsidiary shares
0
Proceeds from ligand purchase agreement, net of expenses
0
Proceeds from the issuance of long-term debt, net
12,500
Impact to cash resulting from deconsolidation certain subsidiaries
1,974
Payment of long-term debt
2,500
Payment of finance lease obligations
7,651
Net cash provided by financing activities
36,593
Effect of exchange rate changes on cash
47
Net decrease in cash, cash equivalents and restricted cash
-39,361
Cash, cash equivalents and restricted cash, beginning of period
44,071
Cash, cash equivalents and restricted cash, end of period
4,710
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
sale of equity
$36,136K
Proceeds from the
issuance of long-term...
$12,500K
Proceeds from sale of
long-term investment
$841K
Proceeds from sale of
property, plant and...
$359K
Proceeds from employee
stock purchases and...
$169K
Net cash provided by
financing activities
$36,593K
Net cash provided by
investing activities
$1,194K
Effect of exchange rate
changes on cash
$47K
Canceled cashflow
$12,212K
Canceled cashflow
$6K
Net decrease in
cash, cash...
-$39,361K
Canceled cashflow
$37,834K
Non-cash interest
expense
$54,440K
Unrealized loss on
long-term investments
-$26,119K
Accounts payable
$23,500K
Share-based compensation
$13,770K
Depreciation and
amortization
$9,999K
Accrued liabilities and
other current...
$4,499K
Other, net
-$2,954K
Prepaid expenses
-$1,260K
Loss (gain) on sale or
disposal of assets, net
-$937K
Loss on impairment of
assets
$234K
Deferred revenue
$1K
Payment of finance lease
obligations
$7,651K
Payment of long-term
debt
$2,500K
Impact to cash
resulting from...
$1,974K
Purchase of treasury
shares to satisfy tax...
$87K
Purchases of property,
plant and equipment
$6K
Net cash used in
operating activities
-$77,195K
Canceled cashflow
$137,713K
Other income
$72,359K
Interest income
$345K
Non-cash royalty revenue
$108,588K
Gain from
deconsolidation of mink...
$100,924K
Net loss
-$3,083K
Accounts receivable
$1,728K
Fair value
adjustments
$387K
Other operating
assets and liabilities
$198K
Canceled cashflow
$72,704K
Revenues
$114,196K
Interest expense
$55,618K
Operating loss
-$20,169K
Canceled cashflow
$114,196K
External expenses
$70,213K
Payroll related
expenses
$39,664K
Other operating
expenses
$24,488K
Buy us a coffee
AGENUS INC (AGEN)
AGENUS INC (AGEN)